Sharescart Research Club logo
Apollo Green 72 (28.6%)ASK Investment 895 (-3.2%)AVPL 49 (0%)Bootes Impex 775 (-8.8%)CIAL 442 (-0.5%)CSK 254 (-3.1%)ESDS Software 478 (2.8%)Garuda Aerospace 468 (-2.1%)Goodluck Defence 385 (16%)Hero Motors 325 (0%)Hinduja Leyland 248 (0%)ICL Fincorp 25 (0%)Incred Holdings 154 (2.7%)Kineco Limited 3285 (0%)Lava 60 (15.4%)Market Simplified 26 (-7.1%)Matrix Gas 12 (-20%)Motilal Oswal 12.25 (-2%)MSEI 6.35 (-2.3%)NCDEX 368 (-1.6%)NSE 1985 (-2%)Onix Renewable 68 (21.4%)OYO 23 (-4.2%)OYO Assets 9.25 (-7%)Philips India 1250 (0%)Polymatech Electronics 56 (-3.4%)SBI Mutual 768 (-0.9%)Taparia Tools 6050 (0%)VCI Chemical 64 (0%)Zepto 40 (-4.8%)

15 Days Price Change

Biopol Chemicals IPO

Closing In

  • days
  • Hours
  • Minutes
  • Seconds
Profile
Issue Size 31.26 Cr
Profile
Price Range 102  to  108 per share
Profile
Min Investment ₹108
Profile
Lot Size 1
Profile
Face Value ₹10
Profile
Draft Prospectus
Invest Before the IPO Goes Live

Buy unlisted shares early and participate in the growth before public listing.

Profile
  • Basic Info
  • IPO Tentative Timetable
  • IPO Lot Size
  • Subscription Status
  • Financials
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Ratios
  • Growth Rates
  • Other info

Overview

Our Company is engaged in the business of manufacturing and distribution of specialty chemicals under the categories ofsilicones, emulsifiers, biochemicals and polyelectrolytes. Our product portfolio consists of 66 products which comprises of40 silicone-based products, 5 emulsifier-based products, 15 biochemical products and 6 polyelectrolyte products. Theseproducts are used in applications across various industry segments, including softeners, emulsions and hardeners fortextiles; silicone fluids and cleaning chemicals for home care; silicone adjuvants and surfactants in agriculture; and releaseagents in industrial chemicals. Read More

Basic Info

Face Value 10 per share

Price 102  to  108 per share

P/E (x) 19.6

Sales( Cr.) 49

PAT( Cr.) 4

EPS 5.5

Draft Prospectus

Exchange NSE-SME

Promoter

Company Promoters

Santanu Sarkar Vedant Sarkar

Pre Issue Share Holding 98.1%

Post Issue Share Holding 65.8%

Listing Details:

Listing Price: 111

Listing Gain: 2.7%

Current Price: 106.5

Gain On Issue: 106.5 | 0%

GMP: 1

GMP %: 0.9 %

IPO Tentative Timetable

Opening Date Feb 06, 2026
Closing Date Feb 10, 2026
Allotment Feb 11, 2026
Refund Feb 12, 2026
Delivery of Shares Feb 12, 2026
Listing Date Feb 13, 2026

IPO Lot Size

Application Lots Shares Amount
Retail (Min) 1 2400 259,200
Retail (Max) -- -- --
S-HNI (Min) 1 2400 259,200
S-HNI (Max) 3 7200 777,600
B-HNI (Min) 4 9600 1,036,800

Objective of the Issue

1. Acquisition of industrial land.2. Repayment or prepayment, in full or in part, of borrowings availed by our Company from banks, financial institutions and non-banking financial companies.3. General corporate purposes.

Issue

Category Nos Bid Bid (x)
QIB 0 14449200 0x
NII 0 26948400 0x
Retail 0 20018400 0x
EMP 0 0 0x
Total 0 61416000 0x

Net Sales (in cr.)

Total Income (in cr.)

Operating Profit (in cr.)

Net Profit (in cr.)

Shareholder Funds (in cr.)

Total Assets (in cr.)

Biopol Chemicals Profit & Loss

#(Fig in Cr.) Mar 2024 Mar 2025 TTM
Net Sales 17 49
Other Income 0 0
Total Income 17 49
Total Expenditure 16 43
Operating Profit 2 7
Interest 0 1
Depreciation 0 0
Exceptional Income / Expenses 0 0
Profit Before Tax 2 6
Provision for Tax 0 1
Profit After Tax 1 4
Adjustments 0 0
Profit After Adjustments 1 4
Adjusted Earnings Per Share 1.6 5.5

Biopol Chemicals Balance Sheet

#(Fig in Cr.) Mar 2024 Mar 2025
Shareholder's Funds 9 14
Minority's Interest 0 0
Borrowings 0 1
Other Non-Current Liabilities 0 0
Total Current Liabilities 8 17
Total Liabilities 18 31
Fixed Assets 0 0
Other Non-Current Assets 0 0
Total Current Assets 17 31
Total Assets 18 31

Biopol Chemicals Cash Flow

#(Fig in Cr.) Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 0 0
Cash Flow from Operating Activities -9 -2
Cash Flow from Investing Activities -0 -0
Cash Flow from Financing Activities 9 3
Net Cash Inflow / Outflow 0 1
Closing Cash & Cash Equivalent 0 1

Biopol Chemicals Ratios

# Mar 2024 Mar 2025
Earnings Per Share (Rs) 1.62 5.47
CEPS(Rs) 1.67 5.56
DPS(Rs) 0 0
Book NAV/Share(Rs) 11.63 17.1
Core EBITDA Margin(%) 10.76 13.3
EBIT Margin(%) 10.53 13.2
Pre Tax Margin(%) 9.82 11.81
PAT Margin (%) 7.35 8.81
Cash Profit Margin (%) 7.58 8.96
ROA(%) 7.31 17.69
ROE(%) 13.92 38.1
ROCE(%) 14.37 38.16
Receivable days 212.12 99.51
Inventory Days 128.41 66.67
Payable days 95.77 56.07
PER(x) 0 0
Price/Book(x) 0 0
Dividend Yield(%) 0 0
EV/Net Sales(x) 0.65 0.29
EV/Core EBITDA(x) 6.08 2.2
Net Sales Growth(%) 0 181.82
EBIT Growth(%) 0 253.24
PAT Growth(%) 0 238.08
EPS Growth(%) 0 238.08
Debt/Equity(x) 0.39 0.57
Current Ratio(x) 2.08 1.81
Quick Ratio(x) 1.34 1.12
Interest Cover(x) 14.8 9.52
Total Debt/Mcap(x) 0 0

Sihora Industries Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 188% 0% 0% 0%
Operating Profit CAGR 250% 0% 0% 0%
PAT CAGR 300% 0% 0% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR NA% NA% NA% NA%
ROE Average 38% 26% 26% 26%
ROCE Average 38% 26% 26% 26%

Company Contact Information

Biopol Chemicals Ltd.

Deepti Nama

+91- 9147076778

investors@biopolchemicals.com

Plot No. 123 & 124 G I D C Phase 1, Vatva

IPO Lead Manager(s)

Biopol Chemicals Ltd.

Smart Horizon Capital Advisors Pvt Ltd.

Registrar Info

Biopol Chemicals Ltd.

Bigshare Services Pvt Ltd

G 10 Left Wing Amruta Village , Opp: Yashoda Hospital,Raj Bhavan Road,Somajiguda,Hyderabad

Frequently Asked Questions

All You Need To Know About IPO

When you leave without vesting, generally unvested ESOPs are cancelled. Vested ESOPs usually can be exercised after you depart, often within 3 to 6 months, depending on the company's ESOP plan.

For companies listed on a stock exchange, you can sell the shares any time after you exercise the ESOP option and the shares are in your demat account. If the company is unlisted or otherwise a startup, you can only sell the shares if and when the company announces a buyback or has a process for secondary sales.

Whenever you exercised your options to hold shares, you entered into a market risk situation, and if the valuation of the company drops, so do the shares.

Yes. ESOPs are valuable to the employer in that the employer is able to retain the best talent, align employee interests with company goals, and preserve cash while rewarding performance.

Wealth Icon
Don’t Miss Out on Unlisted Shares

Open your account today and gain instant access to top unlisted shares and pre-IPO opportunities.

whatsapp